Inventor · disambiguated record
Michael Zamloot
Also filed as: ZAMLOOT MICHAEL · ZAMLOOT MICHAEL S
22 granted patents·13 pending applications·250 citations·filing 2008–2024
96Inventor score
Top patents by PatentIndex Score
35 records- 0197US9517271B2Oral drug delivery systemDURECT CORP·Filed 2015·Granted Dec 13, 2016·21 cites·22 claims
- 0297US9233160B2Oral drug delivery systemDURECT CORP·Filed 2014·Granted Jan 12, 2016·27 cites·23 claims
- 0397US8951556B2Oral drug delivery systemDURECT CORP·Filed 2013·Granted Feb 10, 2015·32 cites·24 claims
- 0497US8945614B2Oral drug delivery systemDURECT CORP·Filed 2013·Granted Feb 3, 2015·32 cites·25 claims
- 0597US8415401B2Oral pharmaceutical dosage formsYUM SU IL·Filed 2008·Granted Apr 9, 2013·64 cites·19 claims
- 0696US8974821B2Oral drug delivery systemDURECT CORP·Filed 2013·Granted Mar 10, 2015·28 cites·25 claims
- 0793US9572885B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2014·Granted Feb 21, 2017·8 cites·26 claims
- 0890US9655861B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2015·Granted May 23, 2017·6 cites·16 claims
- 0990US9555113B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2014·Granted Jan 31, 2017·5 cites·19 claims
- 1089US9592204B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2013·Granted Mar 14, 2017·8 cites·17 claims
- 1188US12391693B2Solid polymorphs of a FLNA-binding compound and its hydrochloride saltsCASSAVA SCIENCES INC·Filed 2024·Granted Aug 19, 2025·1 cites·21 claims
- 1288US12065440B2Solid polymorphs of a FLNA-binding compound and its hydrochloride saltsCASSAVA SCIENCES INC·Filed 2022·Granted Aug 20, 2024·2 cites·3 claims
- 1388US9855333B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2017·Granted Jan 2, 2018·2 cites·25 claims
- 1488US9623017B24:3 naltrexone: 5-methyl-2-furaldehyde cocrystalPAIN THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·10 cites·16 claims
- 1585US11370791B2Solid polymorphs of a FLNA-binding compound and its hydrochloride saltsPAIN THERAPEUTICS INC·Filed 2020·Granted Jun 28, 2022·2 cites·9 claims
- 1680US9918982B2Oral drug delivery systemDURECT CORP·Filed 2016·Granted Mar 20, 2018·1 cites·21 claims
- 1776US2024400566A1Solid polymorphs of a flna-binding compound and its hydrochloride saltsCASSAVA SCIENCES INC·Filed 2024·Application pending·0 cites
- 1874US11096936B2Cocrystals of naloxone and naltrexonePAIN THERAPEUTICS INC·Filed 2016·Granted Aug 24, 2021·1 cites·16 claims
- 1971US2020101021A1Oral pharmaceutical dosage formsDURECT CORP·Filed 2019·Application pending·0 cites
- 2070US2009298862A1Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic conditionYUM SU IL·Filed 2009·Application pending·0 cites
- 2170US2018236078A1Compositions with a Rheological Modifier to Reduce Dissolution VariabilityDURECT CORP·Filed 2018·Application pending·0 cites
- 2269US2018289696A1Oral Drug Delivery SystemDURECT CORP·Filed 2018·Application pending·0 cites
- 2369US2019231702A1Oral Pharmaceutical Dosage FormsDURECT CORP·Filed 2018·Application pending·0 cites
- 2468US10206883B2Oral pharamaceutical dosage formsDURECT CORP·Filed 2017·Granted Feb 19, 2019·0 cites·20 claims
- 2568US9907851B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2016·Granted Mar 6, 2018·0 cites·11 claims
- 2667US9339463B2Micronized opioid compositions having a specific particle size distributionZAMLOOT MICHAEL·Filed 2008·Granted May 17, 2016·0 cites·29 claims
- 2765US10300142B2Compositions with a rheological modifier to reduce dissolution variabilityDURECT CORP·Filed 2017·Granted May 28, 2019·0 cites·20 claims
- 2864US2017319501A1Oral Pharmaceutical Dosage FormsDURECT CORP·Filed 2017·Application pending·0 cites
- 2963US2013317049A1Methods Useful for the Treatment of Pain, Arthritic Conditions or Inflammation Associated with a Chronic ConditionDURECT CORP·Filed 2012·Application pending·0 cites
- 3057US2016228367A1Micronized opioid compositions, formulations and dosage forms and methods of making samePAIN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3153US2016038479A1Compositions with Thixotropy and Enhanced Dissolution Reproducibility and StabilityDURECT CORP·Filed 2014·Application pending·0 cites
- 3249US2009165578A1Dissolution test equipment and methods for testingPAIN THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3348US2019167590A1Micronized Opioid Compositions, Formulations and Dosage Forms and Methods of Making SameZAMLOOT MICHAEL·Filed 2018·Application pending·0 cites
- 3447US10980799B2Crystalline salts of naloxone and naltrexonePAIN THERAPEUTICS INC·Filed 2016·Granted Apr 20, 2021·0 cites·20 claims
- 3547US2014094482A1Benzazocine-ring compound inhibition of tau hyperphosphorylationTHORNTON GEORGE B·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Zamloot files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →